Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Derosa

Showing results (161-170 of 250) with videos related to

Pageof 25
Sort By:
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|September 8, 2012
Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Clinical Therapeutics|December 16, 2004
Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trialGiuseppe Derosa, Arrigo E G Cicero, Gianandrea Bertone, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 16, 2005
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patientsRoberto Fogari, Giuseppe Derosa, Annalisa Zoppi, et al.
Internal Medicine (Tokyo, Japan)|November 21, 2007
Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trialGiuseppe Derosa, Angela D'Angelo, Elena Fogari, et al.
Clinical Therapeutics|October 13, 2004
Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind studyGiuseppe Derosa, Arrigo F G Cicero, Gianandrea Bertone, et al.
Expert Opinion on Pharmacotherapy|November 6, 2012
Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: a 12-month, placebo-controlled studyGiuseppe Derosa, Pietro D Ragonesi, Anna Carbone, et al.
International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung. Journal International De Vitaminologie Et De Nutrition|August 16, 2020
Vitamin D3 supplementation improves glycemic control in type 2 diabetic patients: Results from an Italian clinical trialGiuseppe Derosa, Angela D'Angelo, Chiara Martinotti, et al.
Pharmacological Research|April 30, 2013
RETRACTED: Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patientsGiuseppe Derosa, Pietro D Ragonesi, Anna Carbone, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 26, 2010
Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patientsGiuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, et al.
American Journal of Hypertension|June 21, 2008
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillationRoberto Fogari, Giuseppe Derosa, Ilaria Ferrari, et al.
Pageof 25

Showing results (161-170 of 250) with videos related to

Sort By:
Pageof 25
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|September 8, 2012
Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Clinical Therapeutics|December 16, 2004
Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trialGiuseppe Derosa, Arrigo E G Cicero, Gianandrea Bertone, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 16, 2005
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patientsRoberto Fogari, Giuseppe Derosa, Annalisa Zoppi, et al.
Internal Medicine (Tokyo, Japan)|November 21, 2007
Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trialGiuseppe Derosa, Angela D'Angelo, Elena Fogari, et al.
Clinical Therapeutics|October 13, 2004
Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind studyGiuseppe Derosa, Arrigo F G Cicero, Gianandrea Bertone, et al.
Expert Opinion on Pharmacotherapy|November 6, 2012
Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: a 12-month, placebo-controlled studyGiuseppe Derosa, Pietro D Ragonesi, Anna Carbone, et al.
International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung. Journal International De Vitaminologie Et De Nutrition|August 16, 2020
Vitamin D3 supplementation improves glycemic control in type 2 diabetic patients: Results from an Italian clinical trialGiuseppe Derosa, Angela D'Angelo, Chiara Martinotti, et al.
Pharmacological Research|April 30, 2013
RETRACTED: Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patientsGiuseppe Derosa, Pietro D Ragonesi, Anna Carbone, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 26, 2010
Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patientsGiuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, et al.
American Journal of Hypertension|June 21, 2008
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillationRoberto Fogari, Giuseppe Derosa, Ilaria Ferrari, et al.
Pageof 25